Breast Cancer
New research has uncovered a combination therapy that shows promising results in melanoma and breast cancer models.
Aliya Omer, AstraZeneca, talks about data that backs the efficacy of olaparib in treating high-risk early breast cancer.
In patients with high-risk HER2-psoitive breast cancer, adjuvant trastuzumab emtansine reduces the long-term risk of death.
The study used SEER data of nearly 20,000 cases.
A groundbreaking study has demonstrated that artificial intelligence can enhance breast cancer detection rates by almost 20%.
New research on active monitoring versus surgery in DCIS was presented at SABCS 2024.
People diagnosed with metastatic breast cancer have a notably increased risk of developing heart disease.
Dr. Sadie Debrozsi discusses the importance of "pan-cancer" testing, especially as it pertains to breast cancer.
The CDK4/6 inhibitor showed meaningful improvement in HR+, HER+ disease.
The positive predictive value for cancer was 15% higher for those enrolled.
Advertisement
Expert Interviews on Oncology
Advertisement
DocWire News delivers the latest medical industry news, giving health care professionals the curated content most relevant to their fields and practices.
Get the latest medical updates and insights straight to your inbox.
Advertisement
Section Editor
Dr. Sadie Dobrozsi, EvolentHematologist/oncologist and Medical Director, Evolent
Advertisement
Latest News
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.